Impact of Donor Age on the Outcome of Living-donor Liver Transplantation: Special Consideration to the Feasibility of Using Elderly Donors.


Journal

Transplantation
ISSN: 1534-6080
Titre abrégé: Transplantation
Pays: United States
ID NLM: 0132144

Informations de publication

Date de publication:
01 02 2021
Historique:
pubmed: 3 4 2020
medline: 9 2 2021
entrez: 3 4 2020
Statut: ppublish

Résumé

The use of elderly donors (≥60 y) in living-donor liver transplantation (LDLT) remains controversial. In this study, we aimed to determine the safety of surgery for elderly donors and the impact of donor age on LDLT outcomes. We, retrospectively, reviewed 470 cases of LDLT at Kumamoto University Hospital from December 1998 to March 2017. Donors were divided into 5 groups according to age: 20-29 (n = 109), 30-39 (n = 157), 40-49 (n = 87), 50-59 (n = 81), and ≥60 (n = 36). At our institution, elderly donor candidates required additional preoperative work-up. There were no significant differences in the incidence of postoperative complications and duration of postoperative hospital stay among the 5 donor groups. Regardless of graft type, elderly donors were comparable to younger donor groups (<30 y) in postoperative recovery of liver function. Risk-adjusted overall survival rates of recipients among donor groups were not significantly different. Additionally, donor age was not significantly associated with 6-month graft survival of adult and pediatric recipients. Elderly candidates ≥60 years of age can safely be selected as LDLT donors after meticulous preoperative work-up.

Sections du résumé

BACKGROUND
The use of elderly donors (≥60 y) in living-donor liver transplantation (LDLT) remains controversial. In this study, we aimed to determine the safety of surgery for elderly donors and the impact of donor age on LDLT outcomes.
METHODS
We, retrospectively, reviewed 470 cases of LDLT at Kumamoto University Hospital from December 1998 to March 2017.
RESULTS
Donors were divided into 5 groups according to age: 20-29 (n = 109), 30-39 (n = 157), 40-49 (n = 87), 50-59 (n = 81), and ≥60 (n = 36). At our institution, elderly donor candidates required additional preoperative work-up. There were no significant differences in the incidence of postoperative complications and duration of postoperative hospital stay among the 5 donor groups. Regardless of graft type, elderly donors were comparable to younger donor groups (<30 y) in postoperative recovery of liver function. Risk-adjusted overall survival rates of recipients among donor groups were not significantly different. Additionally, donor age was not significantly associated with 6-month graft survival of adult and pediatric recipients.
CONCLUSIONS
Elderly candidates ≥60 years of age can safely be selected as LDLT donors after meticulous preoperative work-up.

Identifiants

pubmed: 32235254
pii: 00007890-202102000-00013
doi: 10.1097/TP.0000000000003246
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

328-337

Informations de copyright

Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

The authors declare no funding or conflicts of interest.

Références

Tanaka K, Uemoto S, Tokunaga Y, et al. Surgical techniques and innovations in living related liver transplantation. Ann Surg. 1993; 217:82–91
Makuuchi M, Kawasaki S, Noguchi T, et al. Donor hepatectomy for living related partial liver transplantation. Surgery. 1993; 113:395–402
National Institute of Population and Social Security Research in Japan. Population Projections for Japan (2017): 2016 to 2065. 2017. Available at http://www.ipss.go.jp/pp-zenkoku/e/zenkoku_e2017/pp29_summary.pdf . Accessed February, 2020
Kubota T, Hata K, Sozu T, et al. Impact of donor age on recipient survival in adult-to-adult living-donor liver transplantation. Ann Surg. 2018; 267:1126–1133
Kamo N, Kaido T, Hammad A, et al. Impact of elderly donors for liver transplantation: a single-center experience. Liver Transpl. 2015; 21:591–598
Uchiyama H, Shirabe K, Kimura K, et al. Outcomes of adult-to-adult living donor liver transplantation in 321 recipients. Liver Transpl. 2016; 22:305–315
Han JH, You YK, Na GH, et al. Outcomes of living donor liver transplantation using elderly donors. Ann Surg Treat Res. 2014; 86:184–191
Iwamoto T, Yagi T, Umeda Y, et al. The impact of donor age on the outcome of adult living donor liver transplantation. Transplantation. 2008; 85:1240–1245
Yoshizumi T, Shirabe K, Taketomi A, et al. Risk factors that increase mortality after living donor liver transplantation. Transplantation. 2012; 93:93–98
Shirouzu Y, Okajima H, Ogata S, et al. Biliary reconstruction for infantile living donor liver transplantation: Roux-en-Y hepaticojejunostomy or duct-to-duct choledochocholedochostomy? Liver Transpl. 2008; 14:1761–1765
Honda M, Sugawara Y, Kadohisa M, et al. Long-term outcomes of ABO-incompatible pediatric living donor liver transplantation. Transplantation. 2018; 102:1702–1709
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004; 240:205–213
Halldorson JB, Bakthavatsalam R, Fix O, et al. D-MELD, a simple predictor of post liver transplant mortality for optimization of donor/recipient matching. Am J Transplant. 2009; 9:318–326
Umeshita K, Inomata Y, Furukawa H, et al. Liver transplantation in Japan: registry by the Japanese Liver Transplantation Society. Hepatol Res. 2016; 46:1171–1186
Trotter JF, Adam R, Lo CM, et al. Documented deaths of hepatic lobe donors for living donor liver transplantation. Liver Transpl. 2006; 12:1485–1488
Middleton PF, Duffield M, Lynch SV, et al. Living donor liver transplantation–adult donor outcomes: a systematic review. Liver Transpl. 2006; 12:24–30
Beavers KL, Sandler RS, Shrestha R. Donor morbidity associated with right lobectomy for living donor liver transplantation to adult recipients: a systematic review. Liver Transpl. 2002; 8:110–117
Andrade Wde C, Velhote MC, Ayoub AA, et al. Living donor liver transplantation in children: should the adult donor be operated on by an adult or pediatric surgeon? Experience of a single pediatric center. J Pediatr Surg. 2014; 49:525–527
Kadohisa M, Sugawara Y, Shimata K, et al. Duodenal ulcer as a postoperative complication in the donor in living-donor liver transplantation. Transplant Proc. 2018; 50:1129–1131
Akamatsu N, Sugawara Y, Tamura S, et al. Impact of live donor age (>or=50) on liver transplantation. Transplant Proc. 2007; 39:3189–3193
Ono Y, Kawachi S, Hayashida T, et al. The influence of donor age on liver regeneration and hepatic progenitor cell populations. Surgery. 2011; 150:154–161
Ikegami T, Nishizaki T, Yanaga K, et al. The impact of donor age on living donor liver transplantation. Transplantation. 2000; 70:1703–1707
Yoshino K, Taura K, Ikeno Y, et al. Long-term impact and clinical significance of living donor liver transplantation with respect to donor liver restoration and spleen size: a prospective study. Am J Transplant. 2020; 20:808–816
Tanemura A, Mizuno S, Wada H, et al. Donor age affects liver regeneration during early period in the graft liver and late period in the remnant liver after living donor liver transplantation. World J Surg. 2012; 36:1102–1111
Kuramitsu K, Egawa H, Keeffe EB, et al. Impact of age older than 60 years in living donor liver transplantation. Transplantation. 2007; 84:166–172
Schmucker DL, Sanchez H. Liver regeneration and aging: a current perspective. Curr Gerontol Geriatr Res. 2011; 2011:526379
Alexander JW, Vaughn WK. The use of “marginal” donors for organ transplantation. The influence of donor age on outcome. Transplantation. 1991; 51:135–141
Detre KM, Lombardero M, Belle S, et al. Influence of donor age on graft survival after liver transplantation–United Network for Organ Sharing Registry. Liver Transpl Surg. 1995; 1:311–319
Marino IR, Doyle HR, Aldrighetti L, et al. Effect of donor age and sex on the outcome of liver transplantation. Hepatology. 1995; 22:1754–1762
Hoofnagle JH, Lombardero M, Zetterman RK, et al. Donor age and outcome of liver transplantation. Hepatology. 1996; 24:89–96
Busquets J, Xiol X, Figueras J, et al. The impact of donor age on liver transplantation: influence of donor age on early liver function and on subsequent patient and graft survival. Transplantation. 2001; 71:1765–1771
Rustgi SD, Marino G, Halpern MT, et al. Impact of donor age on graft survival among liver transplant recipients: analysis of the United Network for Organ Sharing database. Transplant Proc. 2002; 34:3295–3297
Cuende N, Miranda B, Cañón JF, et al. Donor characteristics associated with liver graft survival. Transplantation. 2005; 79:1445–1452
Gastaca M, Valdivieso A, Pijoan J, et al. Donors older than 70 years in liver transplantation. Transplant Proc. 2005; 37:3851–3854
Cescon M, Grazi GL, Cucchetti A, et al. Improving the outcome of liver transplantation with very old donors with updated selection and management criteria. Liver Transpl. 2008; 14:672–679
Jiménez-Romero C, Clemares-Lama M, Manrique-Municio A, et al. Long-term results using old liver grafts for transplantation: sexagenerian versus liver donors older than 70 years. World J Surg. 2013; 37:2211–2221
Alamo JM, Olivares C, Jiménez G, et al. Donor characteristics that are associated with survival in liver transplant recipients older than 70 years with grafts. Transplant Proc. 2013; 45:3633–3636
Ghinolfi D, Marti J, De Simone P, et al. Use of octogenarian donors for liver transplantation: a survival analysis. Am J Transplant. 2014; 14:2062–2071
Ghinolfi D, Lai Q, Pezzati D, et al. Use of elderly donors in liver transplantation: a paired-match analysis at a single center. Ann Surg. 2018; 268:325–331
Halazun KJ, Rana AA, Fortune B, et al. No country for old livers? Examining and optimizing the utilization of elderly liver grafts. Am J Transplant. 2018; 18:669–678

Auteurs

Masashi Kadohisa (M)

Department of Transplantation and Pediatric Surgery, Kumamoto University, Kumamoto, Japan.

Yukihiro Inomata (Y)

Department of Surgery, Kumamoto Rosai Hospital, Kumamoto, Japan.

Keiichi Uto (K)

Department of Transplantation and Pediatric Surgery, Kumamoto University, Kumamoto, Japan.

Shintaro Hayashida (S)

Department of Transplantation and Pediatric Surgery, Kumamoto University, Kumamoto, Japan.

Yuki Ohya (Y)

Department of Transplantation and Pediatric Surgery, Kumamoto University, Kumamoto, Japan.

Hidekazu Yamamoto (H)

Department of Transplantation and Pediatric Surgery, Kumamoto University, Kumamoto, Japan.

Yasuhiko Sugawara (Y)

Department of Transplantation and Pediatric Surgery, Kumamoto University, Kumamoto, Japan.

Taizo Hibi (T)

Department of Transplantation and Pediatric Surgery, Kumamoto University, Kumamoto, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH